Weight Loss Drugs Show Promise in Preventing Stroke and Reducing Brain Injury Complications
New research reveals that GLP-1 receptor agonists like semaglutide may significantly reduce stroke impacts and improve recovery outcomes.
Researchers Assess Cardiovascular Outcomes in Older Adults Hospitalized with Respiratory Syncytial Virus
RSV hospitalization in older adults links to increased cardiovascular events, highlighting the need for vigilant monitoring and vaccination strategies.
Baxdrostat Reduces Systolic Blood Pressure in Uncontrolled, Treatment-Resistant Hypertension
By targeting aldosterone in a 2-dose regimen, baxdrostat effectively lowers mean seated systolic blood pressure in patients with difficult-to-treat hypertension.
Pirtobrutinib Outperforms Ibrutinib in Head-to-Head Phase 3 Trial for CLL/SLL
Pirtobrutinib shows promising results in a head-to-head trial against ibrutinib for chronic lymphocytic leukemia (CLL)/small lymphocytic leukemia (SLL).
Biosimilar Mvasi Demonstrates Similar Ophthalmic Safety Profile to Reference Product Avastin
A recent study reveals Mvasi’s comparable safety profile to Avastin for retinal diseases, highlighting the need for on-label biosimilars in…
How Decentralized Pharmacists Can Improve Medication Safety Through Team-Based Care
Decentralized pharmacists play a critical role in reducing medication errors by collaborating in real time with physicians and nurses to…
Luspatercept-Aamt Shows Clinically Meaningful Benefits in Reducing Transfusion Burden and Increasing Hemoglobin
Luspatercept shows promise in reducing transfusion dependence for myelofibrosis-associated anemia, despite not meeting primary trial end points.
Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLC
Kevin Chen, PharmD, MS, BCOP, CPP, and Amanda Cass, PharmD, BCPS, BCOP, share key insights about ROS1, non-small cell lung…